172 related articles for article (PubMed ID: 9586675)
1. Relations between surface expression of the interleukin-2 receptor and release of the soluble form of the receptor in cultured mononuclear cells from patients with rheumatoid arthritis or systemic lupus erythematosus.
Itoh M; Goto Y; Ohta Y; Goto Y; Ohashi H
Clin Rheumatol; 1998; 17(1):26-30. PubMed ID: 9586675
[TBL] [Abstract][Full Text] [Related]
2. Impaired urinary excretion of soluble IL-2 receptors in patients with systemic lupus erythematosus and rheumatoid arthritis.
Manoussakis MN; Germanidis GS; Drosos AA; Moutsopoulos HM
Lupus; 1992 Feb; 1(2):105-9. PubMed ID: 1301961
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases.
Manoussakis MN; Papadopoulos GK; Drosos AA; Moutsopoulos HM
Clin Immunol Immunopathol; 1989 Mar; 50(3):321-32. PubMed ID: 2783895
[TBL] [Abstract][Full Text] [Related]
4. Roles of 1,25(OH)2D3 and Vitamin D Receptor in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus by Regulating the Activation of CD4+ T Cells and the PKCδ/ERK Signaling Pathway.
He XJ; Ding Y; Xiang W; Dang XQ
Cell Physiol Biochem; 2016; 40(3-4):743-756. PubMed ID: 27915349
[TBL] [Abstract][Full Text] [Related]
5. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
[TBL] [Abstract][Full Text] [Related]
6. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of the P2X(7) purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis.
Portales-Cervantes L; Niño-Moreno P; Doníz-Padilla L; Baranda-Candido L; García-Hernández M; Salgado-Bustamante M; González-Amaro R; Portales-Pérez D
Hum Immunol; 2010 Aug; 71(8):818-25. PubMed ID: 20493226
[TBL] [Abstract][Full Text] [Related]
8. [Expression of interleukin-6 and its receptors in peripheral blood of patients with systemic lupus erythematosus].
Liu X; Lin H; Yuan G; Huang F
Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):448-50. PubMed ID: 11798678
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Aiolos in Peripheral Blood Mononuclear Cell Subsets from Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Cai X; Liu X; Du S; Xu X; Liu A; Ge X; Qiao Y; Jiang Y
Biochem Genet; 2016 Feb; 54(1):73-82. PubMed ID: 26546109
[TBL] [Abstract][Full Text] [Related]
10. Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
Rozo C; Chinenov Y; Maharaj RK; Gupta S; Leuenberger L; Kirou KA; Bykerk VP; Goodman SM; Salmon JE; Pernis AB
Ann Rheum Dis; 2017 Apr; 76(4):740-747. PubMed ID: 28283529
[TBL] [Abstract][Full Text] [Related]
11. Serum interleukin-2 receptor in systemic lupus erythematosus and rheumatoid arthritis.
Lee GL; Chen MY; Chuang CY; Chen CY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Feb; 21(1):16-22. PubMed ID: 3264781
[TBL] [Abstract][Full Text] [Related]
12. miR-210 expression in PBMCs from patients with systemic lupus erythematosus and rheumatoid arthritis.
Huang Q; Chen SS; Li J; Tao SS; Wang M; Leng RX; Pan HF; Ye DQ
Ir J Med Sci; 2018 Feb; 187(1):243-249. PubMed ID: 28560518
[TBL] [Abstract][Full Text] [Related]
13. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus.
Liu MF; Wang CR; Fung LL; Wu CR
Scand J Immunol; 2004 Feb; 59(2):198-202. PubMed ID: 14871297
[TBL] [Abstract][Full Text] [Related]
14. The analysis of CIS, SOCS1, SOSC2 and SOCS3 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients.
Tsao JT; Kuo CC; Lin SC
Clin Exp Med; 2008 Dec; 8(4):179-85. PubMed ID: 18820827
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis.
Xiong YS; Cheng Y; Lin QS; Wu AL; Yu J; Li C; Sun Y; Zhong RQ; Wu LJ
Rheumatology (Oxford); 2014 Feb; 53(2):250-9. PubMed ID: 24196391
[TBL] [Abstract][Full Text] [Related]
16. Serum soluble CD25 as a risk factor of renal impairment in systemic lupus erythematosus - a prospective cohort study.
Zhang RJ; Zhang X; Chen J; Shao M; Yang Y; Balaubramaniam B; Sun XL; Ambrus JL; He J; Li ZG
Lupus; 2018 Jun; 27(7):1100-1106. PubMed ID: 29482443
[TBL] [Abstract][Full Text] [Related]
17. Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Wang M; Sun H; Zhang W; Zhang Y
BMC Musculoskelet Disord; 2009 Nov; 10():141. PubMed ID: 19919693
[TBL] [Abstract][Full Text] [Related]
18. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
[TBL] [Abstract][Full Text] [Related]
19. Soluble interleukin 2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus.
Raziuddin S; al-Janadi MA; al-Wabel AA
J Rheumatol; 1991 Jun; 18(6):831-6. PubMed ID: 1680190
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of frequency of peripheral blood CD4+; CD25(high);Tregs and CD4+; CD25(low);T cells and expression of PD-1 in SLE and RA patients].
Niu Q; Huang ZC; Cai B; Wang LL; Feng WH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jan; 27(1):23-5. PubMed ID: 21208558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]